BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18270396)

  • 1. Radical radiotherapy treatment (EBRT + HDR-ICRT) of carcinoma of the uterine cervix: outcome in patients treated at a rural center in India.
    Jain VS; Singh KK; Shrivastava R; Saumsundaram KV; Sarje MB; Jain SM
    J Cancer Res Ther; 2007; 3(4):211-7. PubMed ID: 18270396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
    Logsdon MD; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of external-beam radiotherapy alone in invasive cancer of the uterine cervix: a retrospective analysis.
    Saibishkumar EP; Patel FD; Sharma SC; Karunanidhi G; Sankar AS; Mallick I
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):46-51. PubMed ID: 16477919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Gupta IJ; Ghosh A; Yadav J; Tuteja JS; Gupta R; Srivastava K; Verma M; Gupta S; Srivastava S; Bhatt MLB
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3441-3445. PubMed ID: 37898849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
    Chen SW; Liang JA; Yang SN; Lin FJ
    Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
    Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
    Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone.
    Pedersen D; Søgaard H; Overgaard J; Bentzen SM
    Acta Oncol; 1995; 34(6):787-95. PubMed ID: 7576747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
    Le Pechoux C; Akine Y; Sumi M; Tokuuye K; Ikeda H; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):735-41. PubMed ID: 7860384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cervical carcinoma with high-dose rate intracavitary brachytherapy: two years follow-up study.
    Das D; Chaudhuri S; Deb AR; Aich RK; Gangopadhyay S; Ray A
    Asian Pac J Cancer Prev; 2011; 12(3):807-10. PubMed ID: 21627388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix.
    Nakano T; Kato S; Ohno T; Tsujii H; Sato S; Fukuhisa K; Arai T
    Cancer; 2005 Jan; 103(1):92-101. PubMed ID: 15540233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis.
    Bandera L; La Face B; Antonioli C; Galelli M; Ghedi B; Fiume A; Buglione M; Magrini SM; Sartori E
    Eur J Gynaecol Oncol; 2014; 35(2):121-7. PubMed ID: 24772912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy.
    Tan LT; Jones B; Green JA; Kingston RE; Clark PI
    Br J Radiol; 1996 Feb; 69(818):165-71. PubMed ID: 8785646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.